Ignite Creation Date:
2024-05-06 @ 3:51 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04788420
Status:
COMPLETED
Last Update Posted:
2022-06-01
First Post:
2021-03-05
Brief Title:
Influence of Co-existing Mutations on Sorafenib Maintenance Therapy After Allo-HSCT for Patients With FLT3-ITD AML
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Organization Data
Organization:
Nanfang Hospital Southern Medical University
Class:
OTHER
Study ID:
Sorafenib-Flt3 AML-2020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nanfang Hospital Southern Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Qifa Liu
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Nanfang Hospital Southern Medical University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Peking University Peoples Hospital | OTHER |
| Third Affiliated Hospital Sun Yat-Sen University | OTHER |
| Zhujiang Hospital | OTHER |
| Xiangya Hospital of Central South University | OTHER |
| First Peoples Hospital of Chenzhou | OTHER |
| The First Affiliated Hospital of Guangzhou Medical University | OTHER |
| Institute of Hematology Blood Diseases Hospital China | OTHER |
| The First Affiliated Hospital of Soochow University | OTHER |
| Xinqiao Hospital of Chongqing | OTHER |
| First Affiliated Hospital of Zhejiang University | OTHER |